Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 48 blog entries.

26 products added to the Discount Not Deducted (DND) list from February 2023

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 26 new products were classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 February 2023. This took the total number of products granted DND status over the past 2 years to over [...]

The post 26 products added to the Discount Not Deducted (DND) list from February 2023 appeared first on PSNC Website.

By |February 1st, 2023|Lexpos News|Comments Off on 26 products added to the Discount Not Deducted (DND) list from February 2023

January 2023 Price Concessions 4th Update

The Department of Health and Social Care (DHSC) has today (30/01/2023) granted the following list of price concessions for January 2023. Drug Pack Size Price Concession Bumetanide 1mg/5ml oral solution sugar free 150 £235.00 Dutasteride 500microgram capsules 30 £2.95 Fluoxetine 40mg capsules 30 £2.76 Lamotrigine 5mg dispersible tablets sugar free 28 £10.05 Lisinopril 5mg/5ml oral [...]

The post January 2023 Price Concessions 4th Update appeared first on PSNC Website.

By |January 30th, 2023|Lexpos News|Comments Off on January 2023 Price Concessions 4th Update

Pabrinex reclassified as special container

Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of the following products to be supplied as sub-packs: Pabrinex Intramuscular High Potency solution for injection 5ml and 2ml – 20 ampoule 10 x (5ml amps + 2ml amps) Pabrinex Intravenous High Potency solution for injection 5ml [...]

The post Pabrinex reclassified as special container appeared first on PSNC Website.

By |January 30th, 2023|Lexpos News|Comments Off on Pabrinex reclassified as special container

Further SSP updates

Pharmacy contractors should note a number of changes that have been made to different SSPs. SSP Extensions SSP029 for Sandrena® 0.5mg and 1mg gel sachets – restriction has been extended to 28 February 2023. It was previously set to expire on 27 January 2023. SSP030 for Sandrena® 0.5mg and 1mg gel sachets – substitution has been extended [...]

The post Further SSP updates appeared first on PSNC Website.

By |January 27th, 2023|Lexpos News|Comments Off on Further SSP updates

MHRA Drug Safety Update January 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 6 January 2023) has been published and includes articles on: Xaqua (metolazone) 5mg tablets: exercise caution when switching patients between metolazone preparations Topical testosterone (Testogel): risk of harm to children following accidental exposure Electronic Prescribing and Medicines Administration Systems: report [...]

The post MHRA Drug Safety Update January 2023 appeared first on PSNC Website.

By |January 26th, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update January 2023